Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

By sjmartinez • May 13, 2025

Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton LM, Massimino L, Neurath M, Allez M, Atreya R, Snapper SB, Raine T, Ahuja V, Haberman Y, Feagan BG, Jairath V, Vande Casteele N. Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials. J Crohns Colitis. 2025 May 8;19(5):jjaf068. doi: 10.1093/ecco-jcc/jjaf068. PMID: 40295219.

Tags: Cedars Sinai DoM, clinical trials, Digestive Diseases, inflammatory bowel disease, Publications, transcriptomic analysis

Related Posts

Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status

Bazhenova L, Hodgson JG, Camidge DR, Langer CJ, Huber RM, Kim DW, Reckamp KL, Ahn MJ, Tan DSW, Patel JD, Vincent S, Li C, Humphries[...]

Sexually Distinct Multi-Omic Responses to Progressive Endurance Exercise Training in the Rat Lung – Findings from MoTrPAC

Many GM, Sagendorf TJ, Mitchell H, Sanford JA, Cohen S, Misra R, Estevao I, Díaz Ludovico I, Gaul DA, Lindholm ME, Ushakumary MG, Pino J,[...]

Surveying patients to assess timeliness of cancer diagnosis

O'Hanlon CE, Berdahl C, Ye F, Ohana E, Tolpadi A, Bradley MA, Marsolais E, Ptacek M, Henreid AJ, Anhang Price R. Surveying patients to assess[...]